naturally occurring glp-1 agonists for Weight Loss and Diabetes GLP-1 Agonists: A Comprehensive Overview
Description
Commissioned by the World Health Organization, the reviews will contribute to upcoming WHO guidelines on the use of GLP-1 receptor agonists for treating obesity
The purpose of this article is to review the mechanism of action of GLP-1 receptor agonists in type 2 diabetes and discuss the available treatment options in this drug class, including key clinical benefits, safety considerations, and practical information about patient selection, education, prescribing, and safety monitoring
A healthy pregnancy in sickle cell disease is possible
That is usually the moment when a physician considers changing the treatment plan
According to Holst this result was especially encouraging
